palmidrol and am-356

palmidrol has been researched along with am-356 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chambers, JK; Davis, JB; Gray, J; Gunthorpe, MJ; Jerman, JC; Muir, AI; Nasir, S; Randall, AD; Smart, D1
Fowler, CJ; Granberg, M; Jacobsson, SO1
Bottrill, FE; Ford, WR; Hiley, CR; Ho, WS; White, R1
Cichewicz, DL; Haller, VL; Welch, SP1
Goldberg, SR; Luchicchi, A; Melis, M; Muntoni, AL; Pillolla, G; Pistis, M; Yasar, S1

Other Studies

5 other study(ies) available for palmidrol and am-356

ArticleYear
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1).
    British journal of pharmacology, 2000, Volume: 129, Issue:2

    Topics: Amides; Arachidonic Acids; Binding, Competitive; Calcium; Calcium Channels; Cannabinoids; Capsaicin; Cell Line; Cloning, Molecular; Electrophysiology; Endocannabinoids; Ethanolamines; Humans; Hydrogen-Ion Concentration; Palmitic Acids; Patch-Clamp Techniques; Polyunsaturated Alkamides; Receptors, Drug; Recombinant Proteins; TRPV Cation Channels

2000
Effects of the cannabimimetic fatty acid derivatives 2-arachidonoylglycerol, anandamide, palmitoylethanolamide and methanandamide upon IgE-dependent antigen-induced beta-hexosaminidase, serotonin and TNF alpha release from rat RBL-2H3 basophilic leukaemic
    Naunyn-Schmiedeberg's archives of pharmacology, 2001, Volume: 364, Issue:1

    Topics: Adjuvants, Immunologic; Amides; Animals; Arachidonic Acids; beta-N-Acetylhexosaminidases; Endocannabinoids; Enzyme Induction; Ethanolamines; Glycerides; Immunoglobulin E; Inflammation Mediators; Leukemia; Ligands; Mast Cells; Palmitic Acids; Polyunsaturated Alkamides; Rats; Serotonin; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

2001
Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries.
    British journal of pharmacology, 2001, Volume: 134, Issue:4

    Topics: Amides; Animals; Arachidonic Acids; Capsaicin; Coronary Vessels; Dose-Response Relationship, Drug; Endocannabinoids; Endothelium, Vascular; Ethanolamines; Gap Junctions; Glycyrrhetinic Acid; In Vitro Techniques; Indoles; Indomethacin; Male; Palmitic Acids; Peptides; Piperidines; Polyunsaturated Alkamides; Potassium Channel Blockers; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Serotonin; Tetraethylammonium; Vasodilation

2001
Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice.
    European journal of pharmacology, 2006, Sep-28, Volume: 546, Issue:1-3

    Topics: Acetaminophen; Amides; Analgesics; Animals; Arachidonic Acids; Benzamides; Benzoquinones; Camphanes; Capsaicin; Carbamates; Dose-Response Relationship, Drug; Dronabinol; Endocannabinoids; Ethanolamines; Hyperalgesia; Male; Mesencephalon; Mice; Mice, Inbred ICR; Narcotic Antagonists; Pain; Palmitic Acids; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Opioid; Rimonabant; Spinal Cord; TRPV Cation Channels

2006
Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2008, Dec-17, Volume: 28, Issue:51

    Topics: Amides; Amidohydrolases; Animals; Appetite Depressants; Arachidonic Acids; Benzamides; Cannabinoid Receptor Antagonists; Carbamates; Dopamine; Endocannabinoids; Enzyme Activation; Enzyme Inhibitors; Ethanolamines; Injections, Intraventricular; Lipoxygenase Inhibitors; Male; Neurons; Nicotine; Oleic Acids; Organ Culture Techniques; Palmitic Acids; Patch-Clamp Techniques; Piperidines; PPAR alpha; Protein-Tyrosine Kinases; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Rimonabant; Ventral Tegmental Area

2008